Young Adult Latino Testicular Cancer Survivors: a Pilot Study of Goal-Focused Emotion Regulation Therapy (GET)
Part of paid clinical trials in Irvine, California.
- Sponsor
- University of California, Irvine
- Study ID
- NCT07615998
- Status
- Completed
Conditions
- Testicular Cancer
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - 39 Years
- Healthy Volunteers
- Not accepted
Interventions
- Goal-focused Emotion-regulation Therapy — BEHAVIORALGET is a 6-session intervention delivered over 8 weeks to enhance self-regulation through improved goal navigation skills, improved sense of meaning and purpose, and better ability to regulate specific emotional responses. Session topics include a review of cancer-related experiences and influences on goal pursuits, psychoeducation regarding emotions, skills, and values (Session 1), values clarifications and emotional awareness (Session 2), achievability of goals, cognitive skills training (Sessions 3), goal pathway mapping, navigating blocked goals and re-directing energy (Sessions 4), goal motivation and agentic actions, self-care behavior (Session 5), and goal pursuits moving forward (session 6). The first session is 90 minutes and each subsequent session is 60 minutes. Participants are given structured at home exercises via an interactive digital workbook designed to facilitate skill acquisition.
Study Details
Testicular cancer diagnosis and treatment, especially given its threat to sexuality and reproductive health, can be distressing in the formative period of young adulthood. Responsive to the need for feasible, effective, and scalable interventions that meet the needs of ethnic minority men, 35 Hispanic/Latino young adults (ages 18-39) with testicular cancer will receive 6 sessions of GET. We will evaluate primary and secondary outcomes at baseline, post-treatment, and 3-month follow-up. In addition, identified biomarkers will be assessed at baseline and post-intervention.
Key Dates
- Start date
- Aug 5, 2020
- Status verified
- Mar 2025
- Primary completion
- Apr 4, 2023
- Completion
- Aug 14, 2023
Study Design
- Enrollment
- 35 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Goal-focused Emotion-regulation Therapy (GET)GET is a 6-session intervention delivered over 8 weeks to enhance self-regulation through improved goal navigation skills, improved sense of meaning and purpose, and better ability to regulate specific emotional responses. Session topics include a review of cancer-related experiences and influences on goal pursuits, psychoeducation regarding emotions, skills, and values (Session 1), values clarifications and emotional awareness (Session 2), achievability of goals, cognitive skills training (Sessions 3), goal pathway mapping, navigating blocked goals and re-directing energy (Sessions 4), goal motivation and agentic actions, self-care behavior (Session 5), and goal pursuits moving forward (session 6). The first session is 90 minutes and each subsequent session is 60 minutes. Participants are given structured at home exercises via an interactive digital workbook designed to facilitate skill acquisition.
Primary Outcome Measure
Hospital Anxiety and Depression Scale (HADS) [ Time Frame: Baseline (T0), Within 2 weeks of completing last intervention session (T1), Within 2 weeks of 3-months of completing last intervention session (T2) ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California, Irvine | Irvine | California | 92697 | - |
Find similar trials in Irvine, CA
Related Studies
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer SurvivorsRecruiting · University of California, Irvine · Irvine, California
- Unveiling Patient Experiences in Testicular Cancer Clinical TrialsNot Yet Recruiting · Power Life Sciences Inc. · San Francisco, California
- A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid TumorsPHASE1 · Recruiting · Context Therapeutics Inc. · Little Rock, Arkansas